• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清甲胎蛋白对丙型肝炎病毒根除后患者肝细胞癌的早期检测具有高特异性。

Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients.

作者信息

Minami Tatsuya, Tateishi Ryosuke, Kondo Masyuko, Nakagomi Ryo, Fujiwara Naoto, Sato Masaya, Uchino Koji, Enooku Kenichiro, Nakagawa Hayato, Asaoka Yoshinari, Kondo Yuji, Moriya Kyoji, Shiina Shuichiro, Koike Kazuhiko

机构信息

From the Department of Gastroenterology (TM, RT, MK, RN, NF, MS, KU, KE, HN, YA, YK, KK); Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo (KM); Department of Gastroenterology, Juntendo University, Tokyo, Japan (SS).

出版信息

Medicine (Baltimore). 2015 Jun;94(23):e901. doi: 10.1097/MD.0000000000000901.

DOI:10.1097/MD.0000000000000901
PMID:26061310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4616483/
Abstract

Alpha-fetoprotein (AFP) has not played a large role in the surveillance of hepatocellular carcinoma due to inadequate sensitivity and specificity for active chronic hepatitis or cirrhosis. The aim of this study was to evaluate the diagnostic accuracy of AFP in small hepatocellular carcinomas after hepatitis C virus eradication to determine the optimal cutoff value. We conducted a case-control study of 29 cases and 58 controls, matched for age, gender, and platelet counts. The AFP cutoff was 5 ng/mL in patients after hepatitis C virus eradication and 17 ng/mL in those without hepatitis C virus eradication. The areas under the receiver operating characteristic curve were 0.86 (95% confidence interval, 0.76-0.96) in patients after hepatitis C virus eradication and 0.83 (95% confidence interval, 0.74-0.91) in those without hepatitis C virus eradication. In patients after hepatitis C virus eradication, the sensitivity and specificity of AFP levels were 24.1% and 100%, respectively, using a cutoff value of 17 ng/mL. Using a lower cutoff value of 5 ng/mL, the sensitivity increased to 75.9%, although the specificity decreased to 89.0%. AFP is a specific tumor marker for the diagnosis of hepatocellular carcinoma after hepatitis C virus eradication when using the optimal cutoff value of 5 ng/mL.

摘要

由于对活动性慢性肝炎或肝硬化的敏感性和特异性不足,甲胎蛋白(AFP)在肝细胞癌监测中未发挥重要作用。本研究旨在评估丙型肝炎病毒根除后AFP对小肝细胞癌的诊断准确性,以确定最佳临界值。我们进行了一项病例对照研究,纳入29例病例和58例对照,根据年龄、性别和血小板计数进行匹配。丙型肝炎病毒根除后的患者AFP临界值为5 ng/mL,未根除丙型肝炎病毒的患者为17 ng/mL。丙型肝炎病毒根除后的患者中,受试者操作特征曲线下面积为0.86(95%置信区间,0.76 - 0.96),未根除丙型肝炎病毒的患者中为0.83(95%置信区间,0.74 - 0.91)。在丙型肝炎病毒根除后的患者中,使用17 ng/mL的临界值时,AFP水平的敏感性和特异性分别为24.1%和100%。使用5 ng/mL的较低临界值时,敏感性增至75.9%,但特异性降至89.0%。当使用5 ng/mL的最佳临界值时,AFP是丙型肝炎病毒根除后诊断肝细胞癌的特异性肿瘤标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d0/4616483/39e3663003c1/medi-94-e901-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d0/4616483/dba41ccf91d9/medi-94-e901-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d0/4616483/fc304d4c9011/medi-94-e901-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d0/4616483/11d36c9c450d/medi-94-e901-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d0/4616483/39e3663003c1/medi-94-e901-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d0/4616483/dba41ccf91d9/medi-94-e901-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d0/4616483/fc304d4c9011/medi-94-e901-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d0/4616483/11d36c9c450d/medi-94-e901-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d0/4616483/39e3663003c1/medi-94-e901-g006.jpg

相似文献

1
Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients.血清甲胎蛋白对丙型肝炎病毒根除后患者肝细胞癌的早期检测具有高特异性。
Medicine (Baltimore). 2015 Jun;94(23):e901. doi: 10.1097/MD.0000000000000901.
2
Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.慢性丙型肝炎患者(而非肝细胞癌患者)甲胎蛋白升高的预测因素及其在聚乙二醇化干扰素α-2a-利巴韦林联合治疗后的恢复正常情况。
J Gastroenterol Hepatol. 2007 May;22(5):669-75. doi: 10.1111/j.1440-1746.2007.04898.x.
3
Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.异常凝血酶原和甲胎蛋白在乙型肝炎病毒相关性肝细胞癌中的诊断价值
World J Gastroenterol. 2015 Apr 7;21(13):3928-35. doi: 10.3748/wjg.v21.i13.3928.
4
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.慢性肝炎、肝硬化和肝细胞癌患者的去γ-羧基凝血酶原、甲胎蛋白和甲胎蛋白-L3
J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.
5
A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.血清 microRNA 分类器用于早期检测肝细胞癌:一项具有巢式病例对照研究的多中心、回顾性、纵向生物标志物识别研究。
Lancet Oncol. 2015 Jul;16(7):804-15. doi: 10.1016/S1470-2045(15)00048-0. Epub 2015 Jun 15.
6
Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.高尔基体蛋白 73 与甲胎蛋白联合检测在肝细胞癌诊断中的开发及潜在应用。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3302-3310. doi: 10.26355/eurrev_201904_17692.
7
Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.肝硬化患者中α-甲胎蛋白的纵向评估用于肝细胞癌的早期检测
Scand J Gastroenterol. 2019 Oct;54(10):1283-1290. doi: 10.1080/00365521.2019.1673478. Epub 2019 Oct 8.
8
The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.血清甲胎蛋白对肝细胞癌的预测能力与监测目标人群的特征有关。
J Surg Oncol. 2007 Jun 15;95(8):645-51. doi: 10.1002/jso.20653.
9
Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.甲胎蛋白(AFP)在病毒相关性慢性肝病患者筛查中的应用:不同病毒病因是否会影响肝癌患者的AFP水平?一项针对350名西方患者的研究。
Hepatogastroenterology. 2000 Nov-Dec;47(36):1654-8.
10
Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.生长分化因子15血清水平与肝硬化和肝细胞癌的关联
PLoS One. 2015 May 21;10(5):e0127518. doi: 10.1371/journal.pone.0127518. eCollection 2015.

引用本文的文献

1
Normalization of serum alpha fetoprotein after direct acting antivirals in hepatitis C patients lowers hepatocellular carcinoma risk.丙型肝炎患者接受直接抗病毒药物治疗后血清甲胎蛋白正常化可降低肝细胞癌风险。
Sci Rep. 2025 Sep 2;15(1):32312. doi: 10.1038/s41598-025-14861-9.
2
Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis.基于肿瘤标志物和 microRNA-21-5p、IL-17、IL-10 血浆水平的倾向评分整合预测因子可补充用于肝硬化患者肝细胞癌的早期检测。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231212084. doi: 10.1177/15330338231212084.
3

本文引用的文献

1
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.来迪派韦索磷布韦片与索磷布韦联用治疗初治的 HCV 基因 1 型感染。
N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11.
2
ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.ABT-450/r-ombitasvir 和 dasabuvir 联合利巴韦林治疗肝硬化合并丙型肝炎。
N Engl J Med. 2014 May 22;370(21):1973-82. doi: 10.1056/NEJMoa1402869. Epub 2014 Apr 11.
3
Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial.
The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients.
血清甲胎蛋白检测早期肝细胞癌的性能受抗病毒治疗和血清天门冬氨酸氨基转移酶的影响:一项在乙型肝炎病毒感染患者大队列中的研究。
Viruses. 2022 Jul 29;14(8):1669. doi: 10.3390/v14081669.
4
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.腹部超声和甲胎蛋白检测用于诊断慢性肝病成人的肝细胞癌。
Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013346. doi: 10.1002/14651858.CD013346.pub2.
5
Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response.影像学在肝细胞癌管理中的作用:监测、诊断及治疗反应
Hepatoma Res. 2020;6. doi: 10.20517/2394-5079.2020.42. Epub 2020 Aug 27.
6
APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation.APASL HCV 指南:DAA 治愈的 HCV 患者应如何监测 HCC 发生和 HBV 再激活。
Hepatol Int. 2019 Nov;13(6):649-661. doi: 10.1007/s12072-019-09988-7. Epub 2019 Sep 20.
7
Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.在非病毒性肝硬化患者中,利用血清甲胎蛋白检测和腹部超声进行肝细胞癌筛查比单纯使用超声更有效。
J Gastrointest Cancer. 2018 Dec;49(4):476-480. doi: 10.1007/s12029-017-0006-y.
8
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.《亚太地区肝细胞癌管理临床实践指南:2017年更新版》
Hepatol Int. 2017 Jul;11(4):317-370. doi: 10.1007/s12072-017-9799-9. Epub 2017 Jun 15.
9
A Chemiluminescent Protein Microarray Method for Determining the Seroglycoid Fucosylation Index.一种用于测定血清类黏蛋白岩藻糖基化指数的化学发光蛋白质微阵列方法。
Sci Rep. 2016 Aug 16;6:31132. doi: 10.1038/srep31132.
10
Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.升结肠低分化腺癌伴神经内分泌分化患者血清甲胎蛋白升高:病例报告
World J Surg Oncol. 2016 Mar 15;14:84. doi: 10.1186/s12957-016-0838-0.
西美瑞韦提高了治疗经验丰富的 HCV 基因 1 型感染患者持续病毒学应答率:一项 IIb 期试验。
Gastroenterology. 2014 Feb;146(2):430-41.e6. doi: 10.1053/j.gastro.2013.10.058. Epub 2013 Nov 1.
4
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.治疗中甲胎蛋白是接受恩替卡韦治疗的慢性乙型肝炎患者肝细胞癌的特异性肿瘤标志物。
Hepatology. 2014 Mar;59(3):986-95. doi: 10.1002/hep.26739. Epub 2014 Jan 30.
5
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.慢性丙型肝炎合并晚期肝纤维化患者持续病毒学应答与全因死亡率的关系。
JAMA. 2012 Dec 26;308(24):2584-93. doi: 10.1001/jama.2012.144878.
6
Management of hepatocellular carcinoma: an update.肝细胞癌的管理:最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
7
Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy.干扰素治疗后丙型肝炎病毒清除引起的肝细胞癌患者的临床特征和预后。
J Gastroenterol. 2011 Jun;46(6):799-808. doi: 10.1007/s00535-011-0384-z. Epub 2011 Mar 4.
8
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
9
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.衰老对慢性丙型肝炎病毒感染患者发生肝细胞癌风险的影响。
Hepatology. 2010 Aug;52(2):518-27. doi: 10.1002/hep.23691.
10
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.去γ-羧基凝血酶原和甲胎蛋白作为肝癌早期检测的生物标志物。
Gastroenterology. 2010 Feb;138(2):493-502. doi: 10.1053/j.gastro.2009.10.031. Epub 2009 Oct 20.